<SEC-DOCUMENT>0001213900-17-012156-index.html : 20171115
<SEC-HEADER>0001213900-17-012156.hdr.sgml : 20171115
<ACCEPTANCE-DATETIME>20171115120835
ACCESSION NUMBER:		0001213900-17-012156
CONFORMED SUBMISSION TYPE:	NT 10-Q
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20170930
FILED AS OF DATE:		20171115
DATE AS OF CHANGE:		20171115
EFFECTIVENESS DATE:		20171115

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			DanDrit Biotech USA, Inc.
		CENTRAL INDEX KEY:			0001527728
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				452259340
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		NT 10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-54478
		FILM NUMBER:		171204476

	BUSINESS ADDRESS:	
		STREET 1:		STUMPEDYSSEVEJ 17, 2970
		CITY:			H?RSHOLM
		STATE:			G7
		ZIP:			0
		BUSINESS PHONE:		45 39179840

	MAIL ADDRESS:	
		STREET 1:		STUMPEDYSSEVEJ 17, 2970
		CITY:			H?RSHOLM
		STATE:			G7
		ZIP:			0

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Putnam Hills Corp.
		DATE OF NAME CHANGE:	20110810
</SEC-HEADER>
<DOCUMENT>
<TYPE>NT 10-Q
<SEQUENCE>1
<FILENAME>extf10q0917_dandritbiotech.htm
<DESCRIPTION>NOTIFICATION OF LATE FILING
<TEXT>
Document 1 - file: extf10q0917_dandritbiotech.htm

</DOCUMENT>
</SEC-DOCUMENT>